NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Categories: Foundation/nonprofit news release


16-person safety trial mistakenly framed as world’s answer to glaucoma prevention


Clarity is key, especially when release recommends strategy for reducing cognitive dysfunction


Choir singing for cancer patients? PR news release misses the high notes


Generally strong description of diabetic retinopathy drug trial — but more transparency please

1 11/17/2015

TGen uses slippery language to get around fact that “breakthrough” drug for brain tumors never tested in humans


L-DOPA associated with delayed macular degeneration. There’s a patent for that.


Meditation prevents Alzheimer’s? Claims from a foundation news release get ahead of the evidence